Clinical benefit with cisplatin, hydroxyurea and 5- fluorouracil/leucovorin in advanced pancreatic adenocarcinoma [1]

European Journal of Cancer Part A

Volumn 33, Issue 4, 1997, Pages 696-697

  Raymond, E ^a   De Gramont, A ^a   Louvet, C ^a   Tournigand, C ^a   Demuynck, B ^a   Beerblock, K ^a   Carola, E ^a   Krulik, M ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST; STEROID;

ADULT; ADVANCED CANCER; AGED; ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INOPERABLE CANCER; LETTER; LEUKOPENIA; MALE; ORAL DRUG ADMINISTRATION; PANCREAS ADENOCARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; WEIGHT REDUCTION;

EID: 0030990008     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00438-8     Document Type: Article

References (6)

1. Kelly DM, Benjamin IS. Pancreatic carcinoma. Ann Oncol 1995, 6, 19-28.
2. Andersen JS, Burris HA, Casper E, et al. Development of a new system for assessing clinical benefit for patients with advanced pancreatic cancer. Proc Am Soc Clin Oncol 1994, 13, 1600 (abstract).
3. Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5FU-refractory pancreas cancer. Ann Oncol 1996, 7, 347-353.
4. Rougier P, Zarba JJ, Ducreux M, et al. Phase II study of cisplatin and 120-hour continuous infusion of 5 fluorouracil in patients with advanced pancreatic adenocarcinoma. Ann Oncol 1993, 4, 333-336.
5. Louvet C, de Gramont A, Beerblock K, et al. Hydroxyurea, leucovorin, 5FU and cisplatin (HLFP regimen): high response rate and low toxicity in advanced gastric cancer. Proc Am Soc Clin Oncol 1994, 13, 579 (abstract).
6. Louvet C, Beerblock K, de Gramont A, et al. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study. Eur J Cancer 1993, 29A, 1217.